Download PDF
Arthritis und Rheuma 2007; 27(05): 261
DOI: 10.1055/s-0037-1619721
Kallert
Schattauer GmbH

Literatur zum Artikel Kallert

St. Kallert
1   Universität Erlangen-Nürnberg, Medizinische Klinik III
› Author Affiliations
Further Information

Publication History

Publication Date:
24 December 2017 (online)

    Permissions and Reprints

 

 

  • Literatur

  • 1 Agisiu T, Takahashi K, Yagisawa T. et al. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or Anti-B antibody in ABO-incompatible kidney transplantation.. Transpl Proceedings 1992; 24 (02) 1-557.
    Google Scholar
  • 2 Ashworth N, Zochodne D, Hahn A. et al. Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.. Muscle & Nerve 2000; 23 (02) 2-206.
    CrossrefPubMedGoogle Scholar
  • 3 ÄZQ/AWMF (Ärztliche Zentralstelle Qualitätssicherung und Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften): Das Leitlinienmanual der AWMT und ÄZQ.. Z ärztl Fortbild Qual sich (Zae FQ). 2001 95. 01 1-84.
    PubMedGoogle Scholar
  • 4 Bahr F, Gerenkamp Th, Leuner Ch, Kuhn H. Langzeitbeobachtung von KHK-Patienten mit familiärer Hypercholesterinämie im LDL-Apherese-Programm.. Z Kardiol 1995; 84 (Suppl. 03) 64.
    PubMedGoogle Scholar
  • 5 Bosch T, Lennertz A, Schmid B. et al. DALI apheresis in hyperlipidemic patients: Biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.. Artificial Organs 2000; 24 (02) 2-81.
    Google Scholar
  • 6 Bosch T. Current status in extracorporeal immunomodulation: immune disorders.. Artif Organs 1996; 20: 902-905.
    CrossrefPubMedGoogle Scholar
  • 7 Braun N, Kadar JG, Risler T. Ilerapeutic immunoadsorptionits role in clinical practice.. Transfus Sci 1998; (Suppl. 19) 65-69.
    PubMedGoogle Scholar
  • 8 Brunner R, Randolf A, Widder RA. et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration. A randomized trial.. Retina 2000; 20: 483-491.
    PubMedGoogle Scholar
  • 9 Bundesausschuss der Ärzte und Krankenkassen: Richtlinien über die Einführung neuer Untersuchungs- und Behandlungsmethoden (NUB-Richtlinien).. Deutsches Ärzteblatt 1998; 95: 1930-1931.
  • 10 Bundesausschuss der Ärzte und Krankenkassen: Richtlinien zur ambulanten Durchführung der LDL-Elimination.. Deutsches Ärzteblatt 1999; 96: 3000.
  • 11 Cole E, Cattran D, Magil A. et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic glomerulonephritis. The Canadian Apheresis Study Group (see comments).. Am J Kidney Dis 1992; 20: 261-269.
    CrossrefPubMedGoogle Scholar
  • 12 Deutsche Gesellschaft für Kardiologie-, Herz- und Kreislaufforschung: Indikation zur LDL-Eli mination als extrakorporales Hämotherapieverfahren (LDL-Apherese).. Z Kardiol 1997; 86: 478-482.
  • 13 Feld SM, Figueroa P, Savin V. et al. Plasmapheresis in the treatment of steroid-resistent focal segmental glomerulosclerosis in native kidneys.. Am J Kidney Dis 1998; 32 (02) 1-230.
    CrossrefPubMedGoogle Scholar
  • 14 Felix SB, Staudt A, Dörfel WV. et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy. Three month results from a randomized study.. J Am Coll Cardiol 2000; 35: 1590-1598.
    CrossrefPubMedGoogle Scholar
  • 15 Felson DT, Lavalley MP, Baldassarf AR. et al. The Prosorba column for treatment of refractory rheumatoid arthritis.. Arthritis Rheumatism 1999; 42: 2153-2159.
    CrossrefPubMedGoogle Scholar
  • 16 Franke D, Zimmering M, Wolfish N. et al. Treatment of FSGS with plasma exchange and immunoadsorption.. Pediatr Nephrol 2000; 14: 965-969.
    CrossrefPubMedGoogle Scholar
  • 17 Furst D, Felson D, Thoren G, Gendreau RM. Immunoadsorption for the treatment of rheumatold arthritis: final results of a randomized trial.. Therapeutic Apheresis 2000; 4 (05) 2-363.
    Google Scholar
  • 18 Gaubitz M, Seidel M, Kummer S. et al. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.. J Autoimmun 1998; 11: 495-501.
    CrossrefPubMedGoogle Scholar
  • 19 Gjöratrup P, Grino JM, Niartorell J. et al. Antl-HLA antibody removal in hyperimmunized ESRF patients to allow transplantation.. Transpl Proceedings 1991; 23: 392-395.
    Google Scholar
  • 20 Hidaka T, Suzuki K, Matsuki Y. et al. Filtration leucocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.. Arthritis Rheum 1999; 42 (03) 1-431.
    CrossrefPubMedGoogle Scholar
  • 21 Hanai H, Watanabe F, Saniabadi AR. et al. Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis.. Dig Dis Sci 2002; 47 (10) 2349-2353.
    CrossrefPubMedGoogle Scholar
  • 22 Hidaka T, Suzuki K, Matsuki Y. et al. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.. Arthritis Rheum 1999; 42 (03) 431-437.
    CrossrefPubMedGoogle Scholar
  • 23 Higgins RM, Bevan DJ, Carey BS. et al. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.. Lancet 1996; 348: 1208-1211.
    CrossrefPubMedGoogle Scholar
  • 24 Ilhan O, Arat M, Arslan O. et al. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.. Transfus Apher Sci 2004; 30 (03) 185-187.
    CrossrefPubMedGoogle Scholar
  • 25 Kashiwagi N, Sugimura K, Koiwai H. et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.. Dig Dis Sci 2002; 47 (06) 1334-1341.
    CrossrefPubMedGoogle Scholar
  • 26 Klingel R, Fassbender C, Fassbender T. et al. Rheopheresis: Pheologic, functional, and structural aspects.. Therapeutic Apheresis 2000; 4 (05) 2-348.
    Google Scholar
  • 27 Koch F, Fischer I, Hattenbach LO. et al. Rheopheresis for age-related macular degeneration.. Kidney Blood Pressure Research 2001; 24: 415-418.
    Google Scholar
  • 28 Kokalj A, Greinix HT, Ciovica M. et al. Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease.. Clin Immunol 2002; 104 (03) 248-255.
    CrossrefPubMedGoogle Scholar
  • 29 Kosaka T, Sawada K, Ohnishi K. et al. Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn’s Disease.. Intern Med 1999; 38 (02) 1-102.
    CrossrefPubMedGoogle Scholar
  • 30 Lewis EJ, Hunsicker LG, Lan SP. et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.. N Engl J Med 1992; 326 (21) 1-1373.
    CrossrefPubMedGoogle Scholar
  • 31 Maestrangolo F, Pretagostini R, Berloco P. et al. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.. Transplant Proceedings 1995; 27: 892-895.
    Google Scholar
  • 32 McCann SA, Smith SG. Erythrodermic CTCL: a case study of treatment with extracorporeal photopheresis.. Dermatol Nurs 2000; 12 (02) 103-108 111-2.
    PubMedGoogle Scholar
  • 33 Müller J, Wallukat G, Dandel M. et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy.. Circulation 2000; 101: 385-391.
    CrossrefPubMedGoogle Scholar
  • 34 Müller-Wiefel DE, Tönshoff B, Bulla M. et al. Total recovery of acute renal failure (ARF) after dialysed hemolytic uremic syndrome (HUS) treated with or without membrane plasma separation (MPS).. Pediatr Nephrol 2001; 16: 72.
    Google Scholar
  • 35 Nishimura S, Sekiguchi M, Kanol T. et al. Effects of intensive lipid lowering by LDL-apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterinemia: Japan LDL Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).. Atherosclerosis 1999; 144: 409-417.
    CrossrefPubMedGoogle Scholar
  • 36 Ogawa H, Matsumoto Y. The efficacy of plasmapheresis or leucocytapheresis for articular and extraarticular manifestations of rheumatoid arthritis.. Therapeutic Apheresis 1997; 1 (04) 1-330.
    PubMedGoogle Scholar
  • 37 Ohta T, Kawaguchi H, Hattori M. et al. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental gi Qmeruloscierosis in children.. Transplantation 2001; 71: 628-633.
    CrossrefPubMedGoogle Scholar
  • 38 Olbricht CJ, Schleif J, Thiery J. et al. The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods.. Dtsch Med Wschr 1999; 116: 625-630.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Persson NH, Bucin D, Ekberg H. et al. Immunoadsorption in acute vascular rejection after renal transplantation.. Transpl Proceedings 1995; 27 (06) 3466.
    Google Scholar
  • 40 Pusey CD, Rees AJ, Evans DJ. et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.. Kidney Int 1991; 40: 757-763.
    CrossrefPubMedGoogle Scholar
  • 41 Ramlow W, Emmrich J, Ahrenholz P. et al. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.. J Clin Apher 2005; 20 (02) 72-80.
    CrossrefPubMedGoogle Scholar
  • 42 Rech J. Extracorporal therapy in autoimmune diseases and rheumatic processes. arthritis + rheuma 2005; 25 (03) 2-136.
    Google Scholar
  • 43 Reisaeter AV, Leivestad T, Albrechtsen D. Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients.. Transplantation 1999; 60: 242-248.
    Google Scholar
  • 44 Richter WO, Jahn P, Jung N. et al. Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience.. Therapeutic Apheresis 2001; 5: 335-339.
    CrossrefPubMedGoogle Scholar
  • 45 Rock GA, Shumak KH, Buskard NA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.. N Engl J Med 1991; 325-393.
    Google Scholar
  • 46 Ruggenenti P, Galbusera M, Cornejo RP. Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease.. Am J Kidney Dis 1993; 21: 314.
    CrossrefPubMedGoogle Scholar
  • 47 Sawada K, Ohnishi K, Fukui S. et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowei discase.. J Gastroenterol 1995; 30: 322-329.
    CrossrefPubMedGoogle Scholar
  • 48 Sawada K, Ohnishi K, Kosaka T. et al. Leukocytapheresis with leukocyte removal filter as a new therapy for ulcerative colitis.. Therapeutic Apheresis 1999; 1: 207-211.
    Google Scholar
  • 49 Schimke I, Müller J, Priem F. et al. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption.. J Am Coll Cardiol 2001; 38: 178-183.
    CrossrefPubMedGoogle Scholar
  • 50 Schuff-Werner P, Gohlke H, Bartmann U. et al. The HELP-LDL-apheresis multicentre study. An angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentration and the course of Coronary heart disease.. Europ J Clin Invest 1994; 24: 724-732.
    CrossrefPubMedGoogle Scholar
  • 51 Shimoyama T, Sawada K, Hiwatashi N. et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001; 16 (01) 2-1.
    Google Scholar
  • 52 Stegmayr BG, Almroth G, Berlin G. et al. Plasmaexchange or immunadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi Center study.. Int J Artif Organs 1999; 22: 81-87.
    CrossrefPubMedGoogle Scholar
  • 53 Suckfull M, Thifry J, Schorn K. et al. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study.. Acta Otolaryngol (Stockh.) 1999; 119: 763-766.
    CrossrefPubMedGoogle Scholar
  • 54 Suzuki Y, Yoshimura N, Saitoh Y, Saniabadi AR. Granulocyte and monocyte adsorptive apheresis in a case with severe ulcerative colitis unresponsive to conventional medication.. J Clin Apher 2003; 18 (01) 2-40.
    Google Scholar
  • 55 Thiery J, Seidel D. Safety and effectiveness of long-term LDL-apheresis in patients at high risk.. Curr Opin Lipidol 1998; 9: 521-526.
    CrossrefPubMedGoogle Scholar
  • 56 Ueki Y, Nakamura H, Kanamoto Y. et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis.. Ther Apher 2001; 5 (06) 455-461.
    CrossrefPubMedGoogle Scholar
  • 57 Ueki Y, Yamasaki S, Kanamoto Y. et al. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.. Rheumatology (Oxford) 2000; 39 (02) 165-171.
    CrossrefPubMedGoogle Scholar
  • 58 Yamasaki S, Ueki Y, Nakamura H. et al. Effect of filtration leukocytapheresis therapy: modulation of white blood cell enzyme activities in patients with rheumatoid arthritis.. Artif Organs 2002; 26 (04) 378-384.
    CrossrefPubMedGoogle Scholar
  • 59 Zeigler ZR, Shadduck RK, Nath R, Andrews DF. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant associated thrombotic microangiopathy.. Bone Marrow Transplant 1996; 17: 81-82.
    PubMedGoogle Scholar